Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

inTEST Corporation Acquires Alfamation SpA to Strengthen Market Presence and Expand Test Offerings

Elaine Mendonca by Elaine Mendonca
March 12, 2024
in Breaking News
0
Biotechnology Stock Market Today (1)
0
SHARES
7
VIEWS
Share on FacebookShare on Twitter

On March 12, 2024, inTEST Corporation finalized the acquisition of Alfamation S.p.A., a renowned provider of test and measurement solutions across various industries. Alfamation will now be integrated into inTEST’s Electronic Test division, bolstering its automated test offerings and expanding its global market presence.

This strategic acquisition is set to strengthen inTEST’s position in key sectors such as automotive/EV and life sciences, while also increasing exposure in consumer electronics and extending its footprint in Europe. With Alfamation’s reputation for cutting-edge test systems and manufacturing capabilities, the company reported an impressive annual revenue of approximately $25 million in 2023, along with a backlog of around $15 million.

In line with inTEST’s long-term objectives, the acquisition is expected to deliver positive results by 2025 and contribute to a projected revenue increase in 2024, estimated to be within the range of $145 million to $155 million. While there may be an impact on earnings per diluted share in 2024, the acquisition is anticipated to be accretive to non-GAAP adjusted earnings per diluted share due to the associated benefits.

Further details about the acquisition will be discussed during a conference call scheduled for March 13, 2024, as inTEST looks forward to leveraging this strategic move for continued growth and success in the market.

Integrated Device Technology, Inc. (INTT) Stock Analysis and Performance Review – March 12, 2024

On March 12, 2024, the stock performance of Integrated Device Technology, Inc. (INTT) was lackluster as the company’s shares traded near the bottom of its 52-week range and below its 200-day simple moving average. The stock closed at $11.13, marking a decrease of $0.09 or 0.80% since the previous market close.

INTT’s price momentum has been struggling, with the stock trading at lower levels compared to its recent performance. The stock’s price movement indicates a lack of bullish sentiment among investors, as it remains below key technical indicators such as the 200-day moving average.

Despite the drop in share price, INTT did not experience any significant movement in after-hours trading, suggesting that investors were not actively buying or selling the stock after the market closed.

It is important for investors to closely monitor INTT’s performance and consider the factors contributing to its current trading levels. While short-term fluctuations are common in the stock market, understanding the broader market trends and company-specific developments can help investors make informed decisions about their investment strategies.

INTT Stock Analysis: Promising Financial Performance and Growth Potential

On March 12, 2024, INTT stock showed promising performance based on the financial data provided. The company’s total revenue for the past year was $116.83 million, showing a significant increase of 37.64% compared to the previous year. However, the total revenue remained flat since the last quarter at $32.66 million.

Net income for INTT was reported at $8.46 million for the past year, marking a 16.17% increase from the previous year. Additionally, the net income increased by 6.19% since the last quarter, reaching $2.97 million.

Earnings per share (EPS) for INTT stood at $0.78 for the past year, reflecting a 14.75% increase from the previous year. The EPS remained flat since the last quarter at $0.24.

Overall, INTT stock demonstrated strong financial performance with notable increases in total revenue, net income, and EPS compared to the previous year. The company’s ability to maintain steady growth in net income and EPS since the last quarter indicates stability and potential for future growth.

Investors may view INTT stock as a favorable investment option given its consistent financial growth and positive performance indicators. However, it is essential for investors to conduct further research and analysis to make informed investment decisions based on their individual financial goals and risk tolerance.

Tags: INTT
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Finance_ Chart Down

Coinbase Global Inc Announces 1 Billion Convertible Senior Notes Offering

Promising Results of Phase 2 Trial for Paltusotine in Treating Carcinoid Syndrome

PHX Minerals Exceeds Q1 Earnings Expectations Despite Revenue Decline

Recommended

XRP Stock

XRP Faces Resistance as Rally Attempt Falters

2 months ago
Insurance company Stock Bull Market

Analyst Expresses Optimism Towards Travelers Companies and Allstate

2 years ago
Rheinmetall Stock

German Defense Giant Rheinmetall Poised for Major Air Defense Contract

4 months ago
Finance_Capitalistic

Top Stock Picks and Performance Analysis on CNBCs Halftime Report Final Trades

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Camping World’s New Leadership Faces First Major Test

Viking Therapeutics: Upcoming Financial Report to Guide Investor Sentiment

Diginex Enters Critical Implementation Phase Following Strategic Moves

Deluxe Stock Gains Momentum on Successful Fintech Transition

Hydrofarm Holdings: Q4 2025 Earnings Report Date Approaches

Northeast Bancorp Reports Robust Loan Growth Amid Strong Quarterly Performance

Trending

Boston Omaha Stock
Analysis

Investors Await March Report for Boston Omaha’s Strategic Direction

by SiterGedge
February 7, 2026
0

With no recent corporate announcements influencing its share price, market attention has shifted decisively to the upcoming...

Universal Insurance Stock

Universal Insurance Maintains Quarterly Payout Amid Sector Headwinds

February 7, 2026
Embecta Stock

Embecta’s Q1 Performance Outpaces Analyst Forecasts

February 7, 2026
Camping World Stock

Camping World’s New Leadership Faces First Major Test

February 7, 2026
Viking Therapeutics Stock

Viking Therapeutics: Upcoming Financial Report to Guide Investor Sentiment

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Investors Await March Report for Boston Omaha’s Strategic Direction
  • Universal Insurance Maintains Quarterly Payout Amid Sector Headwinds
  • Embecta’s Q1 Performance Outpaces Analyst Forecasts

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com